- Home
- Cryptocurrency
- Tether Dives into Biotech: Injects $200 Million into Blackrock Neurotech
Tether Dives into Biotech: Injects $200 Million into Blackrock Neurotech
![](/media/articles/1714422419.jpg)
Tether, the pioneering stablecoin issuer, is revolutionizing the landscape once again, this time venturing into the promising domain of biotechnology. With a hefty investment of $200 million through its venture arm, Tether Evo, the company establishes itself as the primary stakeholder in Blackrock Neurotech, a renowned player in the realm of brain-computer interface (BCI) technology.
This strategic move propels Tether into the forefront of groundbreaking innovation, aligning with its mission to explore the synergies between technological advancement and human potential. The infusion of funds will empower Blackrock Neurotech to accelerate the commercialization of its revolutionary medical tools and propel its research and development endeavors to new heights.
At the core of Blackrock Neurotech's mission lies the vision to enhance communication, rehabilitation, and cognitive functions through cutting-edge BCI technology. With a track record spanning back to its inception in 2008, the company has consistently pushed the boundaries of what's achievable in the realm of neurotechnology. Notably, in 2016, Nathan Copeland showcased the power of Blackrock's technology by interacting with former U.S. President Barack Obama, marking a pivotal moment in the integration of neuroscience and everyday life.
Introducing tether evo ????✨????
— Tether (@Tether_to) April 29, 2024
From biotech to AI & beyond, Tether's investment in Blackrock Neurotech is just the beginning of our journey into pioneering projects that redefine the boundaries of what's possible, empowering humans throughout the future inevitable evolution. pic.twitter.com/LcCngQPPUZ
Dr. Florian Solzbacher, co-founder of Blackrock Neurotech, emphasizes the significance of the partnership with Tether in propelling healthcare technologies forward. This collaboration heralds a new era of innovation, where finance meets biotech to drive tangible, life-changing outcomes.
Tether's foray into biotech via Tether Evo signifies a strategic diversification beyond its core stablecoin offerings. With additional divisions like Tether Data, Tether Finance, Tether Power, and Tether Education, the company underscores its commitment to integrating technology with human potential, shaping a future where innovation knows no bounds.
As Tether sets sail into uncharted territories, its investment in Blackrock Neurotech heralds a paradigm shift in the intersection of finance and biotechnology. With innovation as its compass, Tether continues to chart a course towards a future where the limits of possibility are redefined, one groundbreaking investment at a time.
Trending
![](/media/articles/thumb/1713207994.jpg)
![](/media/articles/thumb/1713207052.jpg)
Press Releases
Deep Dives
![](/media/articles/thumb/1713202119.jpg)
![](/media/articles/thumb/1702819494.jpg)
![](/media/articles/thumb/1702815162.jpg)